title: Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria.
abstract: Alveolar macrophages are the first line of host defence against mycobacteria, but an insufficient host response allows survival of bacteria within macrophages. We aimed to investigate the role of Toll-like receptor 9 (TLR9) activation in macrophage defence against mycobacteria. Human in vitro differentiated macrophages as well as human and mouse alveolar macrophages showed TLR9 mRNA and protein expression. The cells were markedly activated by DNA isolated from attenuated mycobacterial strains (H37Ra and Mycobacterium bovis BCG) as assessed by measuring cytokine expression by real-time PCR, whereas synthetic phosphorothioate-modified oligonucleotides had a much lower potency to activate human macrophages. Intracellular replication of H37Ra was higher in macrophages isolated from TLR9-deficient mice than in macrophages from wild-type mice, whereas H37Rv showed equal survival in cells from wild-type or mutant mice. Increased bacterial survival in mouse macrophages was accompanied by altered cytokine production as determined by Luminex bead assays. In vivo infection experiments also showed differential cytokine production in TLR9-deficient mice compared to wild-type animals. Both human monocyte-derived macrophages as well as human alveolar macrophages showed reduced activation upon treatment with DNA isolated from bacteria from virulent (M. bovis and H37Rv) compared to attenuated mycobacteria. We suggest attenuated TLR9 activation contributes to the insufficient host response against virulent mycobacteria.
authors.affiliation: Pharmaceutical Biology, Saarland University, Saarbrücken, Germany. pharm.bio.kiemer@mx.uni-saarland.de
authors.forename: Alexandra K
authors.initials: AK
authors.lastname: Kiemer
authors.forename: Ryan H
authors.initials: RH
authors.lastname: Senaratne
authors.forename: Jessica
authors.initials: J
authors.lastname: Hoppstädter
authors.forename: Britta
authors.initials: B
authors.lastname: Diesel
authors.forename: Lee W
authors.initials: LW
authors.lastname: Riley
authors.forename: Koichi
authors.initials: K
authors.lastname: Tabeta
authors.forename: Stefan
authors.initials: S
authors.lastname: Bauer
authors.forename: Bruce
authors.initials: B
authors.lastname: Beutler
authors.forename: Bruce L
authors.initials: BL
authors.lastname: Zuraw
mesh_terms: D000818:Animals; D016207:Cytokines / Q000276:immunology; D004269:DNA, Bacterial / Q000276:immunology*; D006801:Humans; D008262:Macrophage Activation / Q000276:immunology*; D016676:Macrophages, Alveolar / Q000276:immunology* / Q000382:microbiology; D051379:Mice; D008817:Mice, Mutant Strains; D009163:Mycobacterium bovis / Q000276:immunology* / Q000472:pathogenicity; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000472:pathogenicity; D054735:Phosphorothioate Oligonucleotides / Q000276:immunology; D051217:Toll-Like Receptor 9 / Q000096:biosynthesis* / Q000235:genetics; D014397:Tuberculosis, Pulmonary / Q000276:immunology* / Q000382:microbiology
chemical_list: D016207:Cytokines; D004269:DNA, Bacterial; D054735:Phosphorothioate Oligonucleotides; C495371:TLR9 protein, human; C495370:Tlr9 protein, mouse; D051217:Toll-Like Receptor 9